Overview

Dr. Michal Mark Danieli is the founder and CEO of EARLY Labs. A Bio-Convergence startup developing a multi-cancer early detection urine test. She has over 20 years of experience and specialized knowledge in molecular biology, stem cells, cancer research, and Volatile Organic Compounds (VOCs). Dr. Mark Danieli has worked in both the industry and academic world, gaining extensive research and development experience. Previously, Dr. Mark Danieli served as the Co-Founder, General Manager, and CTO of MyScent Diagnostics, and before that worked as a senior researcher and lab manager of genetics and cancer research at the Pediatric Stem Cell Research Institute at Sheba Medical Center, Tel-Aviv. Dr. Michal Mark Danieli earned her B.Sc. in Molecular Biology from the University of San Diego, her M.Sc. (with distinction) in Human Genetics, and her Ph.D. in Cell Research and Immunology from Tel Aviv University.